Faecal calprotectin in treated and untreated children with coeliac disease and juvenile idiopathic arthritis

15Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The present study aimed to provide evidence on whether children at risk of gastrointestinal inflammation have increased measurements of faecal calprotectin (FC). FC was measured in 232 children; 55 children (n=11 treatment naïve) with juvenile idiopathic arthritis (JIA), 63 with coeliac disease (CD); 17 with new diagnosis before and after treatment on glutenfree diet and 114 controls. None of the treatment-naive children with JIA had raised FC. Four JIA patients on treatment had a raised FC but in all cases a repeat test was normal. In newly diagnosed patients with CD, the median (interquartile range) FC was higher 36.4 (26-61) than that in controls 25.0 (23-41) mg/kg (P=0.045) but this significantly decreased 25 (25-25) mg/ kg (P=0.012) after 6 months on gluten-free diet. Random measurements of FC are not raised in children with JIA or CD. A significant elevation of FC in these groups is not explained by their diagnosis and therefore needs further investigation.

Cite

CITATION STYLE

APA

Biskou, O., Gardner-Medwin, J., MacKinder, M., Bertz, M., Clark, C., Svolos, V., … Gerasimidis, K. (2016). Faecal calprotectin in treated and untreated children with coeliac disease and juvenile idiopathic arthritis. Journal of Pediatric Gastroenterology and Nutrition, 63(5), e112–e115. https://doi.org/10.1097/MPG.0000000000001384

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free